Thromboxane development genetic hypertension Lyon rat strain renal biosynthesis thromboxane young hypertensive rats Lyon strain development hypertension Lyon hypertensive female rats thromboxane synthetase inhibitors Dazmegrel OKY thromboxane receptor antagonist AH prehypertensive stage Treatment weeks age Dazmegrel systolic blood pressure weeks age Dazmegrel OKY similar progressive specific reduction urinary excretion thromboxane transient decrease blood pressure level Dazmegrel lasting blood pressure-lowering effect OKY schedule blood pressure level effect week cessation treatment Interestingly active doses thromboxane synthetase inhibitors thromboxane receptor blocker delay antihypertensive properties elevated production thromboxane young Lyon hypertensive rats likely blood pressure regulation effect independent direct vasoconstrictor properties 